Elite Pharmaceuticals Inc (ELTP)

[lasers]

It is vital for everyone to understand that $ELTP's current FDA trial

"The study, which began in March 2017, is a pivotal, open-label, randomized, single-dose, three-way, crossover study to evaluate the relative bioavailability and bioequivalence of the modified formulation of SequestOx™ to the original formulation of SequestOx™ and to a comparator product under fed conditions."

is totally 100% controlled by the FDA and NOT $ELTP.

$ELTP pays for the trial and supplies the SequestOx-II (reformulated SequestOx™ ) and that is the total summation of $ELTP's involvement.

The FDA does the recruitment, gathers the statistical data, makes the Inclusion/Exclusion criteria, and decides if a person has qualified or should be disqualified and replaced throughout the trial.